These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


84 related items for PubMed ID: 2651331

  • 1. Efficacy and safety of enoxacin in the treatment of respiratory infections.
    Scarpazza G, Della Torre F, Scaglione F, Fraschini F.
    Int J Clin Pharmacol Res; 1989; 9(1):43-7. PubMed ID: 2651331
    [Abstract] [Full Text] [Related]

  • 2. [Enoxacin in the treatment of bacterial infections of the respiratory system].
    Marchioni CF, Bernini S, Lunghi P, Guerzoni P.
    Clin Ter; 1989 Jun 30; 129(6):429-36. PubMed ID: 2526704
    [Abstract] [Full Text] [Related]

  • 3. The safety and efficacy of short course (5-day) moxifloxacin vs. azithromycin in the treatment of patients with acute exacerbation of chronic bronchitis.
    DeAbate CA, Mathew CP, Warner JH, Heyd A, Church D.
    Respir Med; 2000 Nov 30; 94(11):1029-37. PubMed ID: 11127487
    [Abstract] [Full Text] [Related]

  • 4. Comparative clinical evaluation of ceftriaxone in treating lower respiratory tract infections.
    Abbate GF, Alagia I, Giaquinto E, Leonessa V, Caputi M, Guarino C, Micillo E, Catena E, Altucci P.
    Chemioterapia; 1986 Feb 30; 5(1):26-32. PubMed ID: 3955779
    [Abstract] [Full Text] [Related]

  • 5. [Treatment of male genital infections with enoxacin].
    Giorgi PM, Giorgi P, Canale D, Turchi P, Poggi MS, Di Coscio M, Bartelloni M, Meschini P, Andreini F, Campa M.
    Arch Ital Urol Nefrol Androl; 1989 Sep 30; 61(3):235-41. PubMed ID: 2529639
    [Abstract] [Full Text] [Related]

  • 6. [Clinical experience of enoxacin complicated urinary tract infection].
    Togashi M, Arakawa M, Tsubo S, Sakashita S, Maru A, Koyanagi T, Nakanishi S, Kakizaki H, Minami S, Kanagawa K.
    Hinyokika Kiyo; 1988 Dec 30; 34(12):2233-6. PubMed ID: 3071131
    [Abstract] [Full Text] [Related]

  • 7. [Enoxacin in the treatment of bacterial prostato-cystitis].
    Mantovani F, Mascheroni E, Dal Prà ML, Montanari E, Mandressi A, Austoni E, Pisani E.
    Arch Ital Urol Nefrol Androl; 1989 Sep 30; 61(3):243-8. PubMed ID: 2529640
    [Abstract] [Full Text] [Related]

  • 8. Cefodizime once daily in the treatment of lower respiratory tract infections.
    Piovano CF, Palombini BC, Dagrosa EE, Mendoza F, Facco EB.
    Arzneimittelforschung; 1997 May 30; 47(5):674-7. PubMed ID: 9205786
    [Abstract] [Full Text] [Related]

  • 9. Double-blind, placebo-controlled clinical evaluation of guaimesal in outpatients.
    Jager EG.
    Clin Ther; 1989 May 30; 11(3):341-62. PubMed ID: 2663163
    [Abstract] [Full Text] [Related]

  • 10. Evaluation of the efficacy of pidotimod in the exacerbations in patients affected with chronic bronchitis.
    Bisetti A, Ciappi G, Bariffi F, Catena E, Rocco V, Vaccaro L, Grassi V, Scarpazza G, Bertoli L, Cardani A.
    Arzneimittelforschung; 1994 Dec 30; 44(12A):1499-502. PubMed ID: 7857351
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. [The effectiveness of enoxacin for the treatment of complicated urinary tract infection].
    Germinario C, Quarto M, Viggiani N, Schena FP.
    Riv Eur Sci Med Farmacol; 1992 Dec 30; 14(5):347-51. PubMed ID: 1308966
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Clinical trial with CO-1177: a preliminary report.
    Mbuyamba P.
    Int J Clin Pharmacol Res; 1986 Dec 30; 6(2):119-21. PubMed ID: 3522442
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. [Clinical studies on enoxacin in urinary tract infection].
    Nagai N, Kaneko S, Akiyama T, Kurita T, Iguchi M, Kataoka K.
    Hinyokika Kiyo; 1988 Jul 30; 34(7):1283-91. PubMed ID: 3051955
    [Abstract] [Full Text] [Related]

  • 19. Comparison of the efficacy and safety of isepamicin and amikacin in the treatment of acute lower respiratory tract infections caused by gram-negative organisms.
    Covi M, Velluti G.
    J Chemother; 1995 Jun 30; 7 Suppl 2():137-42. PubMed ID: 8622102
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 5.